All Content
Agency for Healthcare Quality and Research. Fed Register. June 3, 2022;87: 33795-33796.
Famolaro T, Hare R, Tapia A, et al. Rockville, MD: Agency for Healthcare Research and Quality; April 2022. AHRQ Publication No. 22-0027.
Molefe A, Hung L, Hayes K, et al. Rockville MD: Agency for healthcare Research and Quality; 2022. AHRQ Publication No. 17(22)-0019.
Rockville, MD; Agency for Healthcare Research and Quality: April 2022.
Silver Spring, MD: US Food and Drug Administration; April 5, 2022.
Rockville, MD: Agency for Healthcare Research and Quality; April 2022.
Rockville, MD: Agency for Healthcare Research and Quality; April 7, 2022. RFA-HS-22-008.
Famolaro T, Hare R, Tapia A, et al. Rockville, MD: Agency for Healthcare Research and Quality; March 2022. AHRQ Publication No. 22-0017.
Olson APJ, Danielson J, Stanley J, et al. Rockville, MD: Agency for Healthcare Research and Quality; March 2022. AHRQ Publication No. 22-0026-1-EF
Rockville, MD: Agency for Healthcare Research and Quality; March 2022.
Rockville, MD: Agency for Healthcare Research and Quality; 2020-2022.
Bethesda, MD: National Institute of Neurological Disorders and Stroke. February 10, 2022. Publication No. NOT-NS-22-071.
Rockville, MD: Agency for Healthcare Research and Quality. April 2022 – October 2023
Famolaro T, Hare R, Tapia A, Yount et al. Rockville, MD: Agency for Healthcare Research and Quality; December 2021. AHRQ Publication No. 22-0004.
Rockville, MD: Agency for Healthcare Research and Quality; November 2021. AHRQ Pub. No. 22-0005.
Rockville, MD: Agency for Healthcare Research and Quality; December 2021. AHRQ Publication No. 22-0009.